SCLC

Oncology·MeSH: Small Cell Lung Carcinoma

218 drugs in development·88 companies·8 clinical trials

Drug Pipeline by Phase

Approved(22)

Drug	Company
Alimta®	ELI LILLY & Co (LLY)
cosela	G1 Therapeutics, Inc. (GTHX)
Cyramza	ELI LILLY & Co (LLY)
Cyramza®	ELI LILLY & Co (LLY)
docetaxel	Amneal Pharmaceuticals, Inc. (AMRX)
emrelis	AbbVie Inc. (ABBV)
gavreto	RIGEL PHARMACEUTICALS INC (RIGL)
ibtrozi	Nuvation Bio Inc. (NUVB)
krazati	Mirati Therapeutics, Inc. (MRTX)
krazati	BRISTOL MYERS SQUIBB CO (BMY)
lorbrena	PFIZER INC (PFE)
menacalc	METASTAT, INC. (MTST)
opdivo qvantig	BRISTOL MYERS SQUIBB CO (BMY)
paclitaxel	Mylan II B.V. (MYL)
pemetrexed	DR REDDYS LABORATORIES LTD (RDY)
pemfexy	EAGLE PHARMACEUTICALS, INC. (EGRX)
portrazza	ELI LILLY & Co (LLY)
tevimbra	BeOne Medicines Ltd. (ONC)
Tyvyt	ELI LILLY & Co (LLY)
Tyvyt®	ELI LILLY & Co (LLY)
vizimpro	PFIZER INC (PFE)
Zenocutuzumab (Zeno) / BIZENGRI® (zenocutuzumab-zbco)	Merus N.V. (MRUS)

Phase 3(71)

Drug	Company
Abiraterone - Study	Design Therapeutics, Inc. (DSGN)
Abiraterone - Usual	Design Therapeutics, Inc. (DSGN)
abp 234	AMGEN INC (AMGN)
acasunlimab	Genmab A/S (GMAB)
Administration of ceralasertib	ASTRAZENECA PLC (AZN)
Administration of ceralasertib in combination with AZD5305	ASTRAZENECA PLC (AZN)
Administration of ceralasertib monotherapy	ASTRAZENECA PLC (AZN)
Alectinib - Study	Design Therapeutics, Inc. (DSGN)
Alectinib - Usual	Design Therapeutics, Inc. (DSGN)
Amivantamab	Merus N.V. (MRUS)
Amrubicin	Merus N.V. (MRUS)
aumolertinib	EQRx, Inc. (EQRX)
azacytidine	Merus N.V. (MRUS)
AZD2936	ASTRAZENECA PLC (AZN)
azd7789	ASTRAZENECA PLC (AZN)
bcg+n-803. )	ImmunityBio, Inc. (IBRX)
CAN-2409	Candel Therapeutics, Inc. (CADL)
Ceralasertib	ASTRAZENECA PLC (AZN)
control	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
control arm	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
control arm	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
daraxonrasib	REVOLUTION MEDICINES, INC. (RVMD)
datopotamab deruxtecan	ASTRAZENECA PLC (AZN)
drug	ImmunityBio, Inc. (IBRX)
eftilagimod alfa	IMMUTEP Ltd (PRRUF)
eftilagimod alfa	Immutep Limited (IMMP)
Eftilagimod Alfa	Immutep Limited (IMMP)
eftilagimod alpha	Immutep Limited (IMMP)
eftilagimod alpha	IMMUTEP Ltd (PRRUF)
elironrasib	REVOLUTION MEDICINES, INC. (RVMD)
Enzalutamide	Merus N.V. (MRUS)
Fludrocortisone acetate	Merus N.V. (MRUS)
furmonertinib	ArriVent BioPharma, Inc. (AVBP)
ivonescimab	Summit Therapeutics Inc. (SMMT)
JDQ443	Novartis AG (NVS)
MEDI4736+Tremelimumab	ASTRAZENECA PLC (AZN)
MEDI5752	ASTRAZENECA PLC (AZN)
New Formulation of Niraparib and Abiraterone Acetate	Merus N.V. (MRUS)
olafertinib	Checkpoint Therapeutics, Inc. (CKPT)
osimertinib	GH Research PLC (GHRS)
Osimertinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Pemetrexed	Merck & Co., Inc. (MRK)
Plinabulin	BeyondSpring Inc. (BYSI)
poziotinib	SPECTRUM PHARMACEUTICALS INC (SPPI)
prior failed checkpoint inhibitor	ImmunityBio, Inc. (IBRX)
Raloxifene - Study	Design Therapeutics, Inc. (DSGN)
Raloxifene - Usual	Design Therapeutics, Inc. (DSGN)
rmc-6236	REVOLUTION MEDICINES, INC. (RVMD)
rmc-6291	REVOLUTION MEDICINES, INC. (RVMD)
rmc-9805	REVOLUTION MEDICINES, INC. (RVMD)
Sacituzumab tirumotecan	Merck & Co., Inc. (MRK)
Sacituzumab tirumotecan	Merus N.V. (MRUS)
sintilimab+IBI310+chemotherapy	Merus N.V. (MRUS)
sugemalimab	EQRx, Inc. (EQRX)
Supportive care measures	Merck & Co., Inc. (MRK)
tak-788	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-788	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-928	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-928	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Taletrectinib	Nuvation Bio Inc. (NUVB)
tas6417	CG Oncology, Inc. (CGON)
Telisotuzumab vedotin	AbbVie Inc. (ABBV)
Tislelizumab	ImmunityBio, Inc. (IBRX)
Topotecan	Merus N.V. (MRUS)
Topotecan - study	Design Therapeutics, Inc. (DSGN)
Topotecan - usual	Design Therapeutics, Inc. (DSGN)
Tremelimumab	ASTRAZENECA PLC (AZN)
tsr-042	TESARO, Inc. (TSRO)
zipalertinib	Cullinan Therapeutics, Inc. (CGEM)
Zipalertinib (CLN-081/TAS6417)	Cullinan Therapeutics, Inc. (CGEM)
zl-1310	Zai Lab Ltd (ZLAB)

Phase 2(48)

Drug	Company
Abiraterone acetate tablets	Merus N.V. (MRUS)
ABT-869 .25 mg/kg	AbbVie Inc. (ABBV)
ABT-869 0.10 mg/kg	AbbVie Inc. (ABBV)
adagrasib oral dose of	Mirati Therapeutics, Inc. (MRTX)
Afatinib Oral Tablet	Merus N.V. (MRUS)
alisertib	PUMA BIOTECHNOLOGY, INC. (PBYI)
alk202	SAB BIOTHERAPEUTICS, INC. (SABS)
am0010	ARMO BIOSCIENCES, INC. (ARMO)
amivantamab	ASTRAZENECA PLC (AZN)
BDTX-1535	Black Diamond Therapeutics, Inc. (BDTX)
BMS-986288	CytomX Therapeutics, Inc. (CTMX)
Brigatinib	Merus N.V. (MRUS)
capmatinib	Novartis AG (NVS)
capmatinib	Novartis AG (NVS)
ct053ptsa	SUNSHINE BIOPHARMA INC. (SBFM)
CX-2029	CytomX Therapeutics, Inc. (CTMX)
cylembio	IO Biotech, Inc. (IOBT)
Direct Oral Anticoagulant	Merus N.V. (MRUS)
eflornithine	PANBELA THERAPEUTICS, INC. (SNBP)
Enzalutamide Pill	Merus N.V. (MRUS)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
fs118	F-star Therapeutics, Inc. (FSTX)
inupadenant	iTeos Therapeutics, Inc. (ITOS)
inupadenant (EOS-850)	iTeos Therapeutics, Inc. (ITOS)
JS207 injection +JS004 injection	Merus N.V. (MRUS)
Lurbinectedin	Jazz Pharmaceuticals plc (JAZZ)
MCLA-128	Merus N.V. (MRUS)
MCLA-145	Merus N.V. (MRUS)
mecbotamab vedotin	BioAtla, Inc. (BCAB)
Olaparib	Merus N.V. (MRUS)
Olaparib Pill	Merus N.V. (MRUS)
Oleclumab	ASTRAZENECA PLC (AZN)
osimertinib	SUNSHINE BIOPHARMA INC. (SBFM)
Osimertinib alone	Crinetics Pharmaceuticals, Inc. (CRNX)
Pemetrexed	Merus N.V. (MRUS)
Pemetrexed	iTeos Therapeutics, Inc. (ITOS)
REC-4539	RECURSION PHARMACEUTICALS, INC. (RXRX)
reqorsa	Genprex, Inc. (GNPX)
RP1	ENANTA PHARMACEUTICALS INC (ENTA)
rucosopasem manganese	Galera Therapeutics, Inc. (GRTX)
Sapanisertib (CB-228, formerly TAK-228)	Calithera Biosciences, Inc. (CALA)
Sapanisertib (CB-228)	Calithera Biosciences, Inc. (CALA)
Serplulimab	Merus N.V. (MRUS)
stenoparib	Allarity Therapeutics, Inc. (ALLR)
Telaglenastat (CB-839)	Calithera Biosciences, Inc. (CALA)
vintafolide	ENDOCYTE INC (ECYT)
vopratelimab	Jounce Therapeutics, Inc. (JNCE)
wsd0922-fu	SUNSHINE BIOPHARMA INC. (SBFM)

Phase 1(40)

Drug	Company
[111in]-fpi-2107	ASTRAZENECA PLC (AZN)
ADCT-601	ADC Therapeutics SA (ADCT)
ALX2004	ALX ONCOLOGY HOLDINGS INC (ALXO)
amg 510	AMGEN INC (AMGN)
anvumetostat	AMGEN INC (AMGN)
azacytidine	ENANTA PHARMACEUTICALS INC (ENTA)
AZD2936	Merus N.V. (MRUS)
BI 764532	Merus N.V. (MRUS)
CTX-8371	Compass Therapeutics, Inc. (CMPX)
CV09050101 mRNA vaccine 100 μg	CureVac N.V. (CVAC)
CV09050101 mRNA vaccine 12 μg	CureVac N.V. (CVAC)
CV09050101 mRNA vaccine 25 μg	CureVac N.V. (CVAC)
CV09050101 mRNA vaccine 50 μg	CureVac N.V. (CVAC)
CV09050101 mRNA vaccine 6 μg	CureVac N.V. (CVAC)
cv09070101 mrna vaccine	CureVac N.V. (CVAC)
Danvatirsen	Merus N.V. (MRUS)
Danvatirsen	ASTRAZENECA PLC (AZN)
deltacel	Kiromic Biopharma, Inc. (KRBP)
EB-SELECT Single-Target CAR-NK Cells	Merus N.V. (MRUS)
ec1456	ENDOCYTE INC (ECYT)
enozertinib	Oric Pharmaceuticals, Inc. (ORIC)
fhd-909	Foghorn Therapeutics Inc. (FHTX)
fpi-2053	ASTRAZENECA PLC (AZN)
ICP-189	ArriVent BioPharma, Inc. (AVBP)
IDE397	IDEAYA Biosciences, Inc. (IDYA)
IDE892	IDEAYA Biosciences, Inc. (IDYA)
ko-2806	Kura Oncology, Inc. (KURA)
MEDI5752	Merus N.V. (MRUS)
N-803	ImmunityBio, Inc. (IBRX)
Oleclumab	Merus N.V. (MRUS)
Osimertinib	Jazz Pharmaceuticals plc (JAZZ)
rmc-5127	REVOLUTION MEDICINES, INC. (RVMD)
ryz101 dose level -1	RayzeBio, Inc. (RYZB)
ryz101 dose level 1	RayzeBio, Inc. (RYZB)
ryz101 dose level 2	RayzeBio, Inc. (RYZB)
ryz101 dose level 3	RayzeBio, Inc. (RYZB)
sar408701	Sanofi (SNY)
tno155 in combination with egf816	Novartis AG (NVS)
tpx-0131	Turning Point Therapeutics, Inc. (TPTX)
Zidesamtinib	Nuvalent, Inc. (NUVL)

Preclinical(12)

Drug	Company
apvo455	Aptevo Therapeutics Inc. (APVO)
ATNM-400	Actinium Pharmaceuticals, Inc. (ATNM)
BP1003	BIO-PATH HOLDINGS, INC. (BPTH)
chi3l1 bsabs	Ocean Biomedical, Inc. (OCEA)
chi3l1 mab	Ocean Biomedical, Inc. (OCEA)
Fourth-Generation EGFR Inhibitor	Theseus Pharmaceuticals, Inc. (THRX)
fyarro + adagrasib	Whitehawk Therapeutics, Inc. (WHWK)
primary immune response	Biodesix Inc. (BDSX)
risk of recurrence	Biodesix Inc. (BDSX)
THE-349	Theseus Pharmaceuticals, Inc. (THRX)
til	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
zw220	Zymeworks Inc. (ZYME)

Early Phase 1(1)

Drug	Company
VTP-600	Barinthus Biotherapeutics plc. (BRNS)

N/A(4)

Drug	Company
First-line antihypertensive single-pill combination	Merus N.V. (MRUS)
Nano-crystalline megestrol acetate	Merus N.V. (MRUS)
Yishen Qutong Granules	Merus N.V. (MRUS)
Yishen Qutong Simulant Granules	Merus N.V. (MRUS)

Phase 1/Phase 2(10)

Drug	Company
cetuximab	REVOLUTION MEDICINES, INC. (RVMD)
dji136	Novartis AG (NVS)
dji136	NOVARTIS AG (NVSEF)
hpn328	Harpoon Therapeutics, Inc. (HARP)
jdq443	Novartis AG (NVS)
mrt-2359	Monte Rosa Therapeutics, Inc. (GLUE)
oral mrt-2359	Monte Rosa Therapeutics, Inc. (GLUE)
pemetrexed	REVOLUTION MEDICINES, INC. (RVMD)
regn5093	REGENERON PHARMACEUTICALS, INC. (REGN)
tno155	Novartis AG (NVS)

Phase 2/Phase 3(2)

Drug	Company
Actimab-A	Actinium Pharmaceuticals, Inc. (ATNM)
eik1001	Eikon Therapeutics Inc. (EIKN)

Phase 4(8)

Drug	Company
5-FU	Merus N.V. (MRUS)
Administration of ceralasertib and olaparib	ASTRAZENECA PLC (AZN)
Administration of ceralasertib in combination with olaparib	ASTRAZENECA PLC (AZN)
alectinib	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
alectinib	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
JS207 injection	Merus N.V. (MRUS)
osimertinib	ASTRAZENECA PLC (AZN)
Single agent chemotherapy	Merus N.V. (MRUS)

Compare drugs

Alimta® vs cosela Alimta® vs Cyramza Alimta® vs docetaxel

Frequently asked questions

How many drugs are in development for SCLC?

BioSniper tracks 218 drugs in development for SCLC across 88 companies.

How many clinical trials target SCLC?

There are 8 clinical trials targeting SCLC tracked by BioSniper.

Deep-dive into SCLC

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis